Clinical Trial Update: Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the impact of FOLFIRINOX chemotherapy in stage IV colorectal cancer patients previously exposed to irinotecan, fluoropyrimidine, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFIRINOX

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Colorectal Cancer Stage IV | Phase 2 | Status: UNKNOWN